Key result
SRV2 knockdown attenuates cardiomyocyte death and preserves cardiac function in LPS-induced septic cardiomyopathy by inhibiting mitochondrial fission via the Mst1-Drp1 signaling pathway.
Why the study?
Mitochondrial fission is associated with cardiomyocyte death and myocardial depression, and the role and mechanisms of the pro-fission protein SRV2 in septic cardiomyopathy were not known.
Does SRV2 knockdown prevent mitochondrial fission and cardiomyocyte death in LPS-induced septic cardiomyopathy?
Does SRV2 knockdown prevent mitochondrial fission and cardiomyocyte death in LPS-induced septic cardiomyopathy?
SRV2 promotes mitochondrial fission and cardiomyocyte death via the Mst1-Drp1 axis in septic cardiomyopathy, suggesting SRV2 as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
SRV2 inhibition merits further study in septic cardiomyopathy models; human translation and clinical relevance remain untested.
Mitochondrial fission is associated with cardiomyocyte death and myocardial depression, and suppressor of ras val-2 (SRV2) is a newly discovered pro-fission protein. In this study, we examined the mechanisms of SRV2-mediated mitochondrial fission in septic cardiomyopathy. Western blotting, ELISA, and immunofluorescence were used to evaluate mitochondrial function, oxidative balance, energy metabolism and caspase-related death, and siRNA and adenoviruses were used to perform loss- and gain-of-function assays. Our results demonstrated that increased SRV2 expression promotes, while SRV2 knockdown attenuates, cardiomyocyte death in LPS-induced septic cardiomyopathy. Mechanistically, SRV2 activation promoted mitochondrial fission and physiological abnormalities by upregulating oxidative injury, ATP depletion, and caspase-9-related apoptosis. Our results also demonstrated that SRV2 promotes mitochondrial fission via a Mst1-Drp1 axis. SRV2 knockdown decreased Mst1 and Drp1 levels, while Mst1 overexpression abolished the mitochondrial protection and cardiomyocyte survival-promoting effects of SRV2 knockdown. SRV2 is thus a key novel promotor of mitochondrial fission and Mst1-Drp1 axis activity in septic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Shang et al. (2020) studied Septic cardiomyopathy (n=30). SRV2 knockdown vs. Control / LPS alone was evaluated on Cardiomyocyte death and mitochondrial fission (p=<0.05). SRV2 knockdown attenuates cardiomyocyte death and preserves cardiac function in LPS-induced septic cardiomyopathy by inhibiting mitochondrial fission via the Mst1-Drp1 signaling pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: